Inclusion of Surgery in Multimodality Treatment is Predictive of Better Survival in Stage IIIA Non-small Cell Lung Cancer: An Inverse Probability Treatment-Weighting Analysis

Autor: Lei, Feitong, Sekkath-Veedu, Janeesh, Huang, Bin, Chen, Quan, Shah-Jadeja, Mansi, Stinchcombe, Thomas E., Hao, Zhonglin

Publikováno v: In Clinical Lung Cancer October 2024

TARGETED THERAPY CHANGING NON-SMALL CELL LUNG CANCER PARADIGM: USE OF ALECTINIB IN STAGE III NSCLC

Autor: SELENE, INSIJA, HAO, ZHONGLIN, JOSE, JEMIN, SEKKATH VEEDU, JANEESH

Publikováno v: In Chest October 2023 164(4) Supplement:A4304-A4305

Case report: Uridine triacetate in the management of delayed onset 5-fluorouracil toxicity: A case report and review of literature.

Autor: Jacob A; Department of Hematology and Oncology, Pikeville Medical Center, Pikeville, KY, United States., Sekkath Veedu J; Division of Medical Oncology, Department of Internal Medicine, University of Kentucky, Lexington, KY, United States., Selene I; Division of Medical Oncology, Department of Internal Medicine, University of Kentucky, Lexington, KY, United States., Raj R; Department of Endocrinology, Pikeville Medical Center, Pikeville, KY, United States., Kannan L; Department of Nephrology, Pikeville Medical Center, Pikeville, KY, United States., Patel R; Division of Medical Oncology, Department of Internal Medicine, University of Kentucky, Lexington, KY, United States.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2022 Sep 07; Vol. 13, pp. 977734. Date of Electronic Publication: 2022 Sep 07 (Print Publication: 2022).